Nature reviews research into cybercrime

For all the talk of hard mechanical and technical defences, all human-machine systems are reliant on their soft procedural defences to maintain safety and security. This insight has some traction amongst the safety science community and has now also taken hold in the security community as a recent review by M. Mitchell Waldrop for Nature illustrates.

Cybercrime has become a […]

Is the Cloud still the Future?

Tony Cornford has been cited as expert in an article about Cloud Adoption, entitled ‘Is the Cloud still the Future?’ in Insights (Volume 4).

Asked about the extent of cloud use in the NHS in the UK, he talks about how it is vital to innovation, but also explains the difficultly in determining the extent to which cloud based services […]

January 11th, 2016|Big Data|0 Comments|

Ethical and Security Implications of Emerging Technologies – Dr Nayef Al-Rodhan public lecture

Ethical and Security Implications of Emerging Technologies
Thursday, 7 May 2015 from 17:00 to 18:00 (BST)
Leeds, United Kingdom

Speaker – Dr Nayef Al-Rodhan, philosopher, neuroscientist, geostrategist and author – Honorary Fellow, St.Antony’s College, University of Oxford; Senior Fellow and Director of the Geopolitics and Global Futures Programme, Geneva Centre for Security Policy

Free public lecture open to all.
Online registration required:  https://www.eventbrite.co.uk/e/ethical-and-security-implications-of-emerging-technologies-tickets-16514858386

Human innovation […]

April 13th, 2015|Regulation, Value|0 Comments|

On value base pricing and uncertainty of cost-effectiveness

A new study by colleagues at LSE, Alessandra Ferrario and Panos Kanavos:

Dealing with uncertainty and high prices of new medicines: A comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden, Social Science & Medicine, Volume 124, January 2015, Pages 39-47,

Available at: http://www.sciencedirect.com/science/article/pii/S0277953614007266

A combination of high prices of new patented medicines, […]

November 24th, 2014|Regulation, Value|0 Comments|

A coming book: Controlling Pharmaceutical Risks: Science, Cancer, and the Geneticization of Drug Testing

A book on “the social shaping” of risk assessment, “the social meaning” of “geneticization” and “the public health implications of the consequent ‘reduction’ in this regulatory science for society”:

Controlling Pharmaceutical Risks: Science, Cancer, and the Geneticization of Drug Testing

By John Abraham and Rachel Ballinger

Routledge – 2015 – 224 pages
part of a Genetics and Society series

September 24th, 2014|Regulation, Research, Value|0 Comments|